[pancreas] Role of olaparib in stage 4 pancreatic cancer patients with BRCA mutations

#chemotherapy #pancreaticcancer #brca #treatment
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer

DOI: 10.1200/JCO.21.01604 Journal of Clinical Oncology 40, no. 34 (December 01, 2022) 3929-3939.

Published online July 14, 2022.